• Home
  • NEW DAY MEDICINE
  • 12(50)2022
  • 20 -12 (50) 2022 — Askarov T.A., Ruzimurodov N.F. — THE IMPORTANCE OF DIFFERENTIAL DIAGNOSTICS IN THE TREATMENT OF PATIENTS WITH COVID-19.

20 -12 (50) 2022 — Askarov T.A., Ruzimurodov N.F. — THE IMPORTANCE OF DIFFERENTIAL DIAGNOSTICS IN THE TREATMENT OF PATIENTS WITH COVID-19.

THE IMPORTANCE OF DIFFERENTIAL DIAGNOSTICS IN THE TREATMENT OF PATIENTS WITH COVID-19.

Askarov T.A., Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan

Ruzimurodov N.F. Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan

Resume

Coronavirus infection – is an acute infectious disease caused by a new strain of SARSCoV-2 coronavirus with an aerosol droplet and a home transmission mechanism. Like many researchers, we also studied the features of the course of COVID-19, and decided to analyze in detail one patient in a clinical situation. in our study, we followed all clinical guidelines for diagnosis and treatment protocols, prescribed drugs as recommended Temporary guidelines for the management of patients infected with COVID-19. As a result, the patient after treatment was discharged from the hospital satisfactorily.

Key words: COVID-19, immunology, PCR test, treatment, antiviral therapy.

First page

127

Last page

130

For citation: Askarov T.A., Ruzimurodov N.F. – THE IMPORTANCE OF DIFFERENTIAL DIAGNOSTICS IN THE TREATMENT OF PATIENTS WITH COVID-19. //New Day in Medicine 12(50)2022 127-130 https://clck.ru/336V4B

LIST OF REFERENCES:

  1. Abdelmageed M.I., Abdelmoneim A.H., Mustafa M.I. et al. Design of multi epitope-based peptide vaccine against E protein of human COVID-19: An immunoinformatics approach. //BioRxiv 2020; 2020: 2683286.
  2. Burke R.M., Midgley C.M., Dratch A. et. al. Active monitoring of persons exposed to patients with confirmed COVID-19 – United States, January-February 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 6; 69(9): 245-6.
  3. Caly L., Druce J.D., Catton M.G. et al. The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. //Antiviral Res 2020; 178:104787.
  4. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection – United Kingdom and United States, March-August 2020 https://www.cdc.gov/mmwr/volumes/69/wr/mm6940e1.htm
  5. Cheng H.Y., Jian S.W., Liu D.P. et. al. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med. 2020 May 1 [Epub ahead of print].
  6. Covid-19 Weekly Emidemiological Update (https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19—31-august-2021).
  7. Gupta A., Madhavan M.V., Sehgal K. et. al. Extrapulmonary manifestations of COVID-19. Nat Med 2020; 26: 1017-32.https://doi.org/10.1038/s41591-020-0968-3.
  8. Interim guidelines for the management of patients infected with COVID-19 (fifth version) /Ministry of healthcare of the Republic of Uzbekistan/ Tashkent, 2020
  9. Koh W.C., Naing L., Chaw L. et. al. What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors. PLoS One. 2020 Oct 8; 15(10): e0240205.
  10. Luo L., Liu D., Liao X. et. al. Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China: a prospective cohort study. //Ann Intern Med. 2020 Aug 13 [Epub ahead of print].
  11. Morris S.B., Schwartz N.G., Patel P. et. al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection: United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020 Oct 9 [Epub ahead of print].
  12. Russell B., Moss C., George G. et al (2020) Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence. //Ecancer Med Sci 14:1022. Published 27 Mar 2020
  13. Zhang W., Cheng W., Luo L. et. al. Secondary transmission of coronavirus disease from presymptomatic persons, China. Emerg Infect Dis. 2020 May 26; 26(8).
  14. Zou X., Chen К., Zou J. et. al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020 Apr; 14(2): 185-92.

file

download